1. Home
  2. GNRC vs RGEN Comparison

GNRC vs RGEN Comparison

Compare GNRC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Generac Holdlings Inc.

GNRC

Generac Holdlings Inc.

HOLD

Current Price

$161.19

Market Cap

8.9B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$157.57

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNRC
RGEN
Founded
1959
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9B
8.2B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
GNRC
RGEN
Price
$161.19
$157.57
Analyst Decision
Buy
Buy
Analyst Count
18
10
Target Price
$188.94
$170.90
AVG Volume (30 Days)
934.5K
723.7K
Earning Date
10-29-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
9.08
N/A
EPS
5.26
0.03
Revenue
$4,352,444,000.00
$707,890,000.00
Revenue This Year
$2.01
$17.84
Revenue Next Year
$11.11
$12.57
P/E Ratio
$31.90
$6,353.06
Revenue Growth
5.52
11.74
52 Week Low
$99.50
$102.97
52 Week High
$203.25
$182.52

Technical Indicators

Market Signals
Indicator
GNRC
RGEN
Relative Strength Index (RSI) 51.52 47.50
Support Level $160.01 $160.11
Resistance Level $168.12 $165.02
Average True Range (ATR) 5.48 4.97
MACD 2.35 -1.27
Stochastic Oscillator 71.73 7.12

Price Performance

Historical Comparison
GNRC
RGEN

About GNRC Generac Holdlings Inc.

Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: